Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician
Status
Conditions
Treatments
Details and patient eligibility
About
Heart failure affects more than 1.5 million people in France, resulting in over 70,000 deaths and more than 165,000 hospitalizations each year. Viral and bacterial infections are frequently associated with episodes of acute heart failure in patients with chronic heart failure (CHF). Lower respiratory tract infections, such as influenza and pneumococcus, are common causes of hospitalization for decompensated heart failure, leading to increased morbidity and mortality. Studies have shown that pneumococcal vaccination can reduce the risks of heart attack or stroke in patients with heart failure. However, despite vaccination recommendations, coverage rates remain low, especially for pneumococcus. In this study, we will evaluate the impact of an incentive letter for pneumococcal vaccination on one-year hospitalization rate in patients with heart failure.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Adult patients over 45
- Residing in the Occitanie region, France
- With heart failure registered as ALD
- Who have declared an attending physician
- Who have not received a pneumococcal vaccination for more than 24 months (due to the length of time available in the database)
Exclusion criteria
-None
Trial design
Primary purpose
Allocation
Interventional model
Masking
12,000 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal